LEUKEMIA, B-CELL
Clinical trials for LEUKEMIA, B-CELL explained in plain language.
Never miss a new study
Get alerted when new LEUKEMIA, B-CELL trials appear
Sign up with your email to follow new studies for LEUKEMIA, B-CELL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Gene-Edited immune cells take aim at stubborn leukemia
Disease control Not yet recruitingThis early-phase study is testing a new type of cell therapy for patients whose leukemia has come back or hasn't responded to standard treatments. Doctors take a patient's own immune cells, modify them in a lab to better recognize and attack cancer cells carrying a specific prote…
Matched conditions: LEUKEMIA, B-CELL
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
Experimental drug targets tough blood cancers in early safety trial
Disease control Not yet recruitingThis early-stage trial is testing a new drug called LY4152199 in people with B-cell lymphomas that have returned or didn't respond to previous treatments. The main goals are to find a safe dose and see if the drug shows any signs of helping control the cancer. The study will enro…
Matched conditions: LEUKEMIA, B-CELL
Phase: PHASE1 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC